Dobutamine In Dextrose Injection, Solution
Product Images NDC 51662-1697

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Dobutamine In Dextrose (NDC 51662-1697). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51662 1697 1 Rfid)

This text includes a product code (00351662169711) and some contact or distribution information. The product is intended for prescription use only. For further details, refer to the manufacturer's insert. The distribution is handled by HF Acquisition Co, LLC in Mukilteo, Washington.*

FDA Label Image

Structure (51662 1697 1 Structure 2)

FDA Label Image

Structure (51662 1697 1 Structure)

This is a chemical formula containing organic compounds and their molecular weight. The molecular formula C14H33N1O2HCI indicates the presence of carbon, hydrogen, nitrogen, oxygen, and hydrogen chloride in the chemical compound. The molecular weight of this compound is 337.85.*

FDA Label Image

Table (51662 1697 1 Table 1)

FDA Label Image

Label (51662 1697 1 Source Drug Label)

The text provides information about Dobutamine in 5% Dextrose Injection, USP in a 250 mL single-dose container. It includes details about the drug composition, dosage, warnings (contains sulfites), storage conditions, and manufacturer information. The solution should be clear, sterile, and nonpyrogenic. It is for intravenous use only and should be discarded if unused. The product is distributed by Hospira, Inc. in the USA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.